142 related articles for article (PubMed ID: 31856438)
1. [14-3-3ζ protein mediates gemcitabine resistance in NK/T-cell lymphoma].
Qiu YJ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):906-911. PubMed ID: 31856438
[No Abstract] [Full Text] [Related]
2. IL-13 Contributes to Drug Resistance of NK/T-Cell Lymphoma Cells by Regulating ABCC4.
Ni M; Qin B; Xie L; Zhang X; Yang J; Lv H; Yang M; Zhang M
Biomed Res Int; 2018; 2018():2606834. PubMed ID: 30643796
[TBL] [Abstract][Full Text] [Related]
3. IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4.
Huo J; Fu L; Jin M; Li Z; Zhang M
Invest New Drugs; 2022 Jun; 40(3):537-545. PubMed ID: 35226228
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of Baicalin on Growth of Extranodal NK/T Cell Lymphoma Cells through FOXO3/
Duan XH; Li H; Lyu Y; Liu J; Wang SX; Wu ZT; Wang BX; Lu M; Wang JH; Liang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):730-738. PubMed ID: 37356933
[TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
[TBL] [Abstract][Full Text] [Related]
6. Combination of Gemcitabine and Thymosin alpha 1 exhibit a better anti-tumor effect on nasal natural killer/T-cell lymphoma.
Chen M; Jiang Y; Cai X; Lu X; Chao H
Int Immunopharmacol; 2021 Sep; 98():107829. PubMed ID: 34119916
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness.
Wattanawongdon W; Hahnvajanawong C; Namwat N; Kanchanawat S; Boonmars T; Jearanaikoon P; Leelayuwat C; Techasen A; Seubwai W
Int J Oncol; 2015 Jul; 47(1):398-410. PubMed ID: 25998688
[TBL] [Abstract][Full Text] [Related]
8. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ
Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556
[TBL] [Abstract][Full Text] [Related]
9. [MiR-30b Regulates the Cisplatin-Resistance of Human NK/T Cell Lypnphoma Cell Lines SNK-6 and YTS by Targeting the CCL22].
Wang JH; Liu F; Duan XH; Hao CX; Liu XX; Lu YJ; Wang Z; Liang R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1838-1844. PubMed ID: 31839047
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
[TBL] [Abstract][Full Text] [Related]
11. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance.
D'Errico G; Alonso-Nocelo M; Vallespinos M; Hermann PC; Alcalá S; García CP; Martin-Hijano L; Valle S; Earl J; Cassiano C; Lombardia L; Feliu J; Monti MC; Seufferlein T; García-Bermejo L; Martinelli P; Carrato A; Sainz B
Oncogene; 2019 Jul; 38(27):5469-5485. PubMed ID: 30936462
[TBL] [Abstract][Full Text] [Related]
13. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
14. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.
Hu W; Liu Q; Pan J; Sui Z
Biomed Pharmacother; 2018 Sep; 105():887-898. PubMed ID: 30021382
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cisplatin sensitivity in human breast cancer MCF-7 cell line through BiP and 14-3-3ζ co-knockdown.
Kashkoulinejad-Kouhi T; Safarian S; Arnaiz B; Saa L
Oncol Rep; 2021 Feb; 45(2):665-679. PubMed ID: 33416155
[TBL] [Abstract][Full Text] [Related]
16. Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway.
Wu ZH; Lin C; Liu MM; Zhang J; Tao ZH; Hu XC
PLoS One; 2016; 11(12):e0169230. PubMed ID: 28036386
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
[TBL] [Abstract][Full Text] [Related]
18. sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.
Wu S; Zhang X; Dong M; Yang Z; Zhang M; Chen Q
Oncol Rep; 2020 Oct; 44(4):1467-1478. PubMed ID: 32945520
[TBL] [Abstract][Full Text] [Related]
19. [Synergistic Antitumor Effect of Everolimus Combined with Gemcitabine on Diffuse Large B-Cell Lymphoma].
Zuo XQ; Tan CL; Li XM; Ma T
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):81-88. PubMed ID: 36765481
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]